Literature DB >> 6637933

Failure of naloxone to reverse clonidine toxic effect.

W Banner, M E Lund, L Clawson.   

Abstract

Acute ingestions of imidazoline compounds, including clonidine hydrochloride, are a recognized clinical entity. The signs and symptoms of this overdose superficially resemble those of opiate intoxication, leading to attempts to reverse this poisoning with naloxone hydrochloride. Despite previous descriptions of success using naloxone in acute clonidine poisoning, five cases of acute pediatric ingestions of clonidine ranging from mild to severe occurred in which naloxone hydrochloride in doses up to 0.1 mg/kg was unsuccessful in reversing the signs and symptoms of this intoxicant. Although naloxone can be safely administered to children who ingest clonidine to distinguish them from those who are intoxicated by opiates, it is not therapeutically useful to use naloxone to reverse poisoning with this class of agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6637933     DOI: 10.1001/archpedi.1983.02140380030009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

1.  Unintentional pediatric ophthalmic tetrahydrozoline ingestion: case files of the medical toxicology fellowship at the University of California, San Francisco.

Authors:  Suad A Al-Abri; He S Yang; Kent R Olson
Journal:  J Med Toxicol       Date:  2014-12

2.  Clonidine casualty.

Authors:  M Sanklecha; A Jog; K Raghavan
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 3.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

4.  Pediatric tizanidine toxicity reversed with naloxone: a case report.

Authors:  Doaa Bader; Ahmed Adam; Mohamed Shaban; Bader Alyahya
Journal:  Int J Emerg Med       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.